CodeLink activated slides use SurModics’s PhotoLink technology to create a three-dimensional matrix that allows the attachment of biomolecules to form microarrays.
Bruce Barclay, president and CEO of SurModics, said: “Our acquisition of the CodeLink activated slide business further demonstrates our commitment to building an even stronger in vitro technologies business by leveraging SurModics’s core competencies.
“Selling these products directly will allow us to get closer to our customers and offer a broader range of products, which is consistent with our strategic growth initiative of diversification.”